Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Patient Self-Reporting of Symptoms
OTHER
2 trials
Sponsors
Alliance Foundation Trials, LLC.
, Institut de Cancérologie de Lorraine
Conditions
Metastatic Cancer
Solid Tumor
Unknown Phase
Electronic Patient Reporting of Symptoms During Cancer Treatment
Completed
NCT03249090
Alliance Foundation Trials, LLC.
Metastatic Cancer
Start: 2017-10-30
End: 2023-08-30
Updated: 2025-01-14
Artificial Intelligence to Search for Abnormalities in Ambulatory Cancer Patients
Completed
NCT05412420
Institut de Cancérologie de Lorraine
Solid Tumor
Start: 2022-08-03
End: 2023-10-13
Updated: 2023-11-30
Related Papers
Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer
UNC Libraries
2026-01-09
Impact of Providing an Automated Telephone Option to Report Weekly Patient-Reported Outcome Measures in the PRO-TECT Trial (AFT-39) on Disparity Gaps in Symptom Management and Outcomes
JCO Clinical Cancer Informatics
2025-05-01
Symptom monitoring with electronic patient-reported outcomes during cancer treatment: final results of the PRO-TECT cluster-randomized trial.
2025-02-07
16 citations
Identification of meaningful individual-level change thresholds for worsening on the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE®).
UNC Libraries
2024-11-15
Identification of meaningful individual-level change thresholds for worsening on the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE®)
Quality of Life Research
2024-11-06
2 citations
Electronic patient-reported outcomes monitoring during lung cancer chemotherapy: A nested cohort within the PRO-TECT pragmatic trial (AFT-39)
UNC Libraries
2022-12-02
A randomized controlled trial of routine financial toxicity screening via electronic patient-reported outcomes (AFT-39).
Journal of Clinical Oncology
2022-09-30
4 citations
Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer
JAMA
2022-06-05
331 citations
Clinical Utility and User Perceptions of a Digital System for Electronic Patient-Reported Symptom Monitoring during Routine Cancer Care: Findings from the PRO-TECT Trial
UNC Libraries
2022-05-20
6 citations
Remote, proactive, telephone based management of toxicity in outpatients during adjuvant or neoadjuvant chemotherapy for early stage breast cancer: pragmatic, cluster randomised trial
BMJ
2021-12-08
45 citations
Digital symptom monitoring with patient-reported outcomes in community oncology practices: A U.S. national cluster randomized trial.
Journal of Clinical Oncology
2021-11-23
19 citations
Electronic patient-reported outcomes monitoring during lung cancer chemotherapy: A nested cohort within the PRO-TECT pragmatic trial (AFT-39).
2021-09-30
20 citations
Abstract PO-119: Separate and unequal: Examining the role of race and site of care on patient-reported outcomes among patients with metastatic cancer (AFT-39)
Cancer Epidemiology Biomarkers & Prevention
2020-11-30
Clinical Utility and User Perceptions of a Digital System for Electronic Patient-Reported Symptom Monitoring During Routine Cancer Care: Findings From the PRO-TECT Trial
JCO Clinical Cancer Informatics
2020-10-28
176 citations
Nurse, oncologist, and patient impressions of electronic symptom monitoring via patient-reported outcomes in community oncology practices: Qualitative results from the U.S. national PRO-TECT trial (AFT-39, NCT03249090).
Journal of Clinical Oncology
2020-05-20
1 citations
Barriers to minority recruitment in a multicenter clinical trial (PRO-TECT [AFT-39]): Research staff insights.
Journal of Clinical Oncology
2019-09-20
Methods for alerting clinicians to concerning symptom questionnaire responses during cancer care: Approaches from two randomized trials (STAR, AFT-39 PRO-TECT).
Journal of Clinical Oncology
2018-09-25
1 citations